These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 17556589

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J, Du ZM, Chen MH, Lin JK, Hu PJ.
    Zhonghua Yi Xue Za Zhi; 2008 May 27; 88(20):1390-3. PubMed ID: 18953876
    [Abstract] [Full Text] [Related]

  • 5. [Changes of intercellular spaces of esophageal epithelium in patients with gastroesophageal reflux disease before and after esomeprazole treatment].
    Tao J, Xiao YL, Chen MH, Peng S, Lin JK, Xiong LS, Hu PJ.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):392-5. PubMed ID: 17456380
    [Abstract] [Full Text] [Related]

  • 6. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
    Grigolon A, Cantù P, Savojardo D, Conte D, Penagini R.
    J Clin Gastroenterol; 2008 Oct 06; 42(9):969-73. PubMed ID: 18719508
    [Abstract] [Full Text] [Related]

  • 7. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
    Johnsson F, Hatlebakk JG, Klintenberg AC, Román J, Toth E, Stubberöd A, Falk A, Edin R.
    Scand J Gastroenterol; 2003 Apr 06; 38(4):354-9. PubMed ID: 12739706
    [Abstract] [Full Text] [Related]

  • 8. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.
    Am J Gastroenterol; 2008 Oct 06; 103(10):2446-53. PubMed ID: 18684197
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
    Johnson DA, Orr WC, Crawley JA, Traxler B, McCullough J, Brown KA, Roth T.
    Am J Gastroenterol; 2005 Sep 06; 100(9):1914-22. PubMed ID: 16128933
    [Abstract] [Full Text] [Related]

  • 11. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study.
    Moawad FJ, Betteridge JD, Boger JA, Cheng FK, Belle LS, Chen YJ, Maydonovitch CL, Wong RK.
    Aliment Pharmacol Ther; 2013 May 06; 37(10):1011-8. PubMed ID: 23560727
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G, Wenzl TG, Thomson M, Omari T, Barker P, Lundborg P, Illueca M.
    J Pediatr; 2013 Sep 06; 163(3):692-8.e1-2. PubMed ID: 23800403
    [Abstract] [Full Text] [Related]

  • 13. Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease.
    Omari T, Lundborg P, Sandström M, Bondarov P, Fjellman M, Haslam R, Davidson G.
    J Pediatr; 2009 Aug 06; 155(2):222-8. PubMed ID: 19394048
    [Abstract] [Full Text] [Related]

  • 14. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC, Weusten BL, Numans ME, de Wit NJ, Samsom M, Smout AJ.
    J Clin Gastroenterol; 2008 Aug 06; 42(5):441-7. PubMed ID: 18344896
    [Abstract] [Full Text] [Related]

  • 15. Measuring esophageal distension by high-frequency intraluminal ultrasound probe.
    Rhee PL, Liu J, Puckett JL, Mittal RK.
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct 06; 283(4):G886-92. PubMed ID: 12223348
    [Abstract] [Full Text] [Related]

  • 16. A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease.
    Dent J, Kahrilas PJ, Hatlebakk J, Vakil N, Denison H, Franzén S, Lundborg P.
    Am J Gastroenterol; 2008 Jan 06; 103(1):20-6. PubMed ID: 18184117
    [Abstract] [Full Text] [Related]

  • 17. Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual.
    Katzka DA, Sidhu M, Castell DO.
    Am J Gastroenterol; 1995 Feb 06; 90(2):280-4. PubMed ID: 7847301
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.
    Omari T, Davidson G, Bondarov P, Nauclér E, Nilsson C, Lundborg P.
    J Pediatr Gastroenterol Nutr; 2007 Nov 06; 45(5):530-7. PubMed ID: 18030229
    [Abstract] [Full Text] [Related]

  • 19. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
    Lemire S.
    Can J Gastroenterol; 1997 Sep 06; 11 Suppl B():37B-40B. PubMed ID: 9347176
    [Abstract] [Full Text] [Related]

  • 20. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.
    Shetler KP, Bikhtii S, Triadafilopoulos G.
    Dis Esophagus; 2017 Jun 01; 30(6):1-8. PubMed ID: 28475749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.